Project description
Real-time monitoring of AD pathophysiology
Alzheimer’s disease (AD) constitutes the most common form of age-related dementia, and its prevalence is expected to increase, given the rising ageing population. To find effective new treatments, we need to understand the disease-related mechanisms and find ways to monitor them. Funded by the Marie Skłodowska-Curie Actions programme, the FLORIN project proposes an innovative nanotechnology-based bioimaging approach to monitor key mechanisms implicated in AD pathogenesis. Researchers plan to develop a real-time device with temperature biosensing and molecular bioimaging capacity to detect related changes in living tissues. The idea is to advance the diagnosis of AD at an early stage and improve the quality of life of afflicted individuals.
Fields of science
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- engineering and technologyenvironmental biotechnologybiosensing
- natural sciencesphysical sciencesopticsmicroscopysuper resolution microscopy
- engineering and technologynanotechnologynano-materials
- engineering and technologynanotechnologynanophotonics
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-AG-UN - HORIZON Unit Grant
Coordinator
70211 Kuopio
Finland
See on map
Participants (6)
89081 Ulm
See on map
00 927 Warszawa
See on map
02300 Vilnius
See on map
76227 Karlsruhe
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
84084 Fisciano Sa
See on map
03233 Vilnius
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (2)
27617 Raleigh
See on map
G1K 9A9 Quebec
See on map